Cargando…

Evaluation of the FAS and FASL Gene changes in women with premature ovarian failure: A case-control study

BACKGROUND: Premature ovarian failure (POF), is menopause occurring before the age of 40, affecting 1-3% of women worldwide. The risk of POF increases with altered immunological parameters such as FAS and FASL genes, which play a fundamental role in embryogenesis and cellular homeostasis. OBJECTIVE:...

Descripción completa

Detalles Bibliográficos
Autores principales: Akhavansales, Zhima, Mosadeghmehrjardi, Alimohammad, Reza Ashrafzadeh, Hamid, Fakhteh Yavari, Shadnaz, Taher Tahoori, Mohammad, Bitaraf Sani, Morteza, Mohammadi, Mahnaz, Montazeri, Fateme, Ghasemi, Nasrin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Knowledge E 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9928975/
https://www.ncbi.nlm.nih.gov/pubmed/36819201
http://dx.doi.org/10.18502/ijrm.v20i12.12561
Descripción
Sumario:BACKGROUND: Premature ovarian failure (POF), is menopause occurring before the age of 40, affecting 1-3% of women worldwide. The risk of POF increases with altered immunological parameters such as FAS and FASL genes, which play a fundamental role in embryogenesis and cellular homeostasis. OBJECTIVE: The study aimed to investigate the potential role of FAS and FASL genes in POF pathogenesis. MATERIALS AND METHODS: In this case-control study, the polymorphisms of FAS-670A/G and FASLIVS2nt_124A/G apoptotic genes were analyzed in 51 Iranian women suffering from POF, and 61 healthy controls. Isolation of DNA was done using the salting-out method, and genotypic analysis was performed for all the subjects using the polymerase chain reaction-restriction fragment length polymorphism method. RESULTS: Our results revealed that homozygous FAS-670A/A and G/G, and heterozygous FAS-670A/G are not significantly different between cases and controls (p = 0.99). Also, in different genotyping models of FASIVS2nt_124, polymorphisms were not related to POF risk (p = 0.23). CONCLUSION: There is no statistical association between these polymorphisms and POF risk in women referred to genetic counseling clinics.